Furthermore, investigations by Little and colleagues demonstrated that intranasal delivery of Cpn to wild type BALB/c mice resulted in the organism’s presence in the olfactory bulbs and further in the brain along with identification of amyloid pathology (Little et al., 2005; Little et al., 2014). The gene discussed is CPN1; the disease is amyloidosis.